Equity Details
Price & Market Data
Price: $23.50
Daily Change: +$0.02 / 0.09%
Daily Range: $22.95 - $24.00
Market Cap: $3,389,693,440
Daily Volume: 1,201,359
Performance Metrics
1 Week: -2.89%
1 Month: 9.00%
3 Months: 85.19%
6 Months: 198.6%
1 Year: 1,694%
YTD: 165.2%
About Tango Therapeutics, Inc. (TNGX)
Key metrics for Tango Therapeutics, Inc. (TNGX). Current price: 23.50, daily change: +$0.02 / 0.09%. Market cap: 3,389,693,440. Performance across all periods for quick analysis.
Company Details
Employees: 137
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase (STK) 11 loss-of-function mutations to treat lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.